JPRN-UMIN000048778
Not yet recruiting
未知
Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin. - Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin.
Iwate Medical University School of Medicine0 sites20 target enrollmentStarted: August 28, 2022Last updated:
Conditionscirrhotic patient
Overview
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Iwate Medical University School of Medicine
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with liver cancer in more advanced stage than BCLC\-C stage 2\) Patients who will be treated for hepatocellular carcinoma within the study period. 3\) Patients with serious bone or muscle disease or cardiac, pulmonary, renal, or cerebrovascular disease. 4\) Pregnant or lactating women and patients who may or intend to become pregnant.
Investigators
Similar Trials
Recruiting
Phase 4
Prevention of sarcopenia by biologic agents and JAK inhibitors in rheumatoid arthritis; PRESENT studyJPRN-UMIN000037797Department of Orthopaedic surgery, Osaka City General Hospital200
Withdrawn
Not Applicable
Improvement of Sarcopenia in Patients Following Two Different DietsSarcopeniaNCT03405727Brugmann University Hospital
Recruiting
Not Applicable
An intervention study to prevent sarcopenia in hospitalized patientsType2 diabetesJPRN-jRCTs051190108Ikeda Kaori80
Not yet recruiting
Not Applicable
Sarcopenia Intervention for Breast Cancer PatientsNeoplasmsKCT0008961Yonsei University72
Recruiting
Not Applicable
Efficacy of exercse therapy for sarcopenia preventionin dialysis patientschronic kidney diseaseJPRN-UMIN000037460fukui saiseikai hospital50